United States: Alvotech And Teva's Selarsdi™ (ustekinumab-aekn), Biosimilar To Stelara® Approved By FDA - Venable LLP

Wednesday, 1 May 2024 (2 weeks ago)
According to an April 2024 press release, Alvotech and Teva's Selarsdi™ (ustekinumab-aekn) was approved by the FDA on April 16 as a biosimilar of Janssen / Johnson & Johnson's Stelara® (ustekinumab).

👓 View full article

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Nvidia & darpa biohybrid

https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..

Credit: Rumble Duration: 55:45Published on March 29, 2024

United States: Alvotech And Teva's Selarsdi™ (ustekinumab-aekn), Biosimilar To Stelara® Approved By FDA - Venable LLP

You Might Like

Related videos from verified sources